Neuromuscular Mechanisms Underlying Poor Recovery From Whiplash Injuries

January 8, 2021 updated by: James Elliott, Northwestern University
This study is investigating whether changes in the shape and size of bodily muscles and spinal cord anatomy can influence recovery rates following a motor vehicle collision (MVC). The objective is to demonstrate that the presence of muscle and spinal cord degeneration and associated muscle weakness is the consequence of a mild MVC-related injury involving the cervical spinal cord.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Whiplash is a condition that consists of patients that display varying degrees of pain and disability. Most patients should expect full-recovery within the first 2-3 months post injury. At the other end of the spectrum is a group of patients (~ 25%) who continue to have moderate-severe pain-related disability in the long-term. Reasons for this transition to chronicity are largely unknown. The situation would benefit if there were radiological findings of the disorder. However, clear and consistent findings of injured tissues on standard radiological exams remain elusive.

As part of this study, the investigators will innovatively investigate measures to 1) quantify the temporal development of widespread muscle degeneration, 2) identify quantifiable markers of altered cervical spinal cord physiology, 3) quantify reductions in central activation and fatigue 4) evaluate potential genetic variants that may be associated with chronic pain after a MVC and 5) determine the mediational influence of psychosocial factors on recovery rates following whiplash injury, as a potential mechanism underlying the transition to chronic pain.

Study Type

Interventional

Enrollment (Actual)

97

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Illinois
      • Chicago, Illinois, United States, 60611
        • Northwestern University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Males and Females (18 - 65 years of age)
  • Individuals less than one week post MVA with a primary complaint of neck pain.
  • Able to give written informed consent and complete interviews in English

Exclusion Criteria:

  • Individuals with a spinal fracture from the MVA, or spinal surgeries
  • History of one or more MVAs or previous diagnosis of cervical or lumbar radiculopathy
  • History of neurological disorders (e.g. Multiple Sclerosis, previous stroke, myelopathy), inflammatory diseases (e.g. Hepatitis, Systemic Lupus Erythematosus, Rheumatoid Arthritis or Osteoarthritis, Alzheimers, Ankylosing Spondylitis, Crohn's disease, Fibromyalgia) or metabolic disorders (e.g. Diabetes, hyper- and hypo-thyroidism)
  • Standard contraindications to MRI: claustrophobia, metallic implants, pacemaker and pregnancy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: DIAGNOSTIC
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Procedures
RNA/DNA blood sample will be collected. Participant will complete questionnaires, MRI and strength and reflex testing.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
MRI to assess the changes in markers of altered cervical spinal cord physiology and muscle degeneration.
Time Frame: < 1 week; 2 weeks; 3 months; 1 year of MVC
< 1 week; 2 weeks; 3 months; 1 year of MVC

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Neck Disability Index (NDI) Questionnaire
Time Frame: <1 week; 2 weeks, 3 months; 1 year of MVC
This questionnaire will access the influence of psychosocial factors on recovery rates over a period of time.
<1 week; 2 weeks, 3 months; 1 year of MVC
Coping Strategy Questionnaire-C
Time Frame: < 1 week; 2 weeks; 3 months; 1 year of MVC
This questionnaire will access the influence of psychosocial factors and recovery rates over a period of time.
< 1 week; 2 weeks; 3 months; 1 year of MVC
Pain Management Inventory (PMI) Questionnaire
Time Frame: < 1 week; 2 weeks; 3 months; 1 year of MVC
This questionnaire will access the influence of psychosocial factors and recovery rates over a period of time.
< 1 week; 2 weeks; 3 months; 1 year of MVC
Tampa Questionnaire
Time Frame: < 1 week; 2 weeks, 3 months; 1 year of MVC
This questionnaire will access the influence of psychosocial factors and recovery rates over a period of time.
< 1 week; 2 weeks, 3 months; 1 year of MVC
Post-traumatic Diagnostic Scale (PDS) Questionnaire
Time Frame: < 1 week; 2 weeks; 3 months; 1 year of MVC
This questionnaire will access the influence and psychosocial factors and recovery rates over a period of time.
< 1 week; 2 weeks; 3 months; 1 year of MVC
Impact of Events Scale Questionnaire
Time Frame: < 1 week; 2 weeks; 3 months; 1 year of MVC
This questionnaire will access the influence of psychosocial factors and recovery rates over a period of time.
< 1 week; 2 weeks; 3 months; 1 year of MVC
Center for Epidemiological Studies - Depression Scale Questionnaire
Time Frame: < 1 week; 2 weeks; 3 months; 1 year of MVC
This questionnaire will access the influence of psychosocial factors and recovery rates over a period of time.
< 1 week; 2 weeks; 3 months; 1 year of MVC
Hospital Anxiety and Depression Scale Questionnaire
Time Frame: < 1 week; 2 weeks; 3 months; 1 year of MVC
This questionnaire will access the influence of psychosocial factors and recovery rates over a period of time.
< 1 week; 2 weeks; 3 months; 1 year of MVC
Traumatic Injuries Distress Scale and a Symptom Index
Time Frame: < 1 week; 2 weeks; 3 months; 1 year after MVC
This questionnaire will access the influence of psychosocial factors and recovery rates over a period of time.
< 1 week; 2 weeks; 3 months; 1 year after MVC
Prediction of Post-MVC Chronic Axial Pain Assessment
Time Frame: Baseline visit
This questionnaire will access the influence of psychosocial factors and recovery rates over a period of time.
Baseline visit
Follow-Up Data Collection Form for clinical prediction
Time Frame: 2 week; 3 month; 1 year of MVC
This questionnaire will access the influence of psychosocial factors and recovery rates over a period of time.
2 week; 3 month; 1 year of MVC
Pedometer: wear for 2 consecutive weeks
Time Frame: 2 weeks; 3 months after MVC
The pedometer will record changes in activity level.
2 weeks; 3 months after MVC
RNA and DNA blood collection
Time Frame: within a week of MVC
The samples will evaluate potential genetic variants that may be associated with chronic pain after a MVC.
within a week of MVC
Strength and reflex testing in the lower leg
Time Frame: 2 weeks; 3 months; 1 year
This testing will demonstrate changes in central activation and fatigue.
2 weeks; 3 months; 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: James M Elliott, PhD, Northwestern University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2014

Primary Completion (Actual)

May 1, 2020

Study Completion (Actual)

May 1, 2020

Study Registration Dates

First Submitted

May 30, 2014

First Submitted That Met QC Criteria

June 4, 2014

First Posted (Estimate)

June 5, 2014

Study Record Updates

Last Update Posted (Actual)

January 12, 2021

Last Update Submitted That Met QC Criteria

January 8, 2021

Last Verified

January 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • STU00090769

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Whiplash

Clinical Trials on MRI

3
Subscribe